Literature DB >> 22815273

Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor.

Susana Orozco1, Michael A Schmid1, Poornima Parameswaran1, Ruben Lachica1, Matthew R Henn2, Robert Beatty3,1, Eva Harris1.   

Abstract

Dengue virus (DENV) causes dengue fever and dengue haemorrhagic fever/dengue shock syndrome, both considered major public-health problems worldwide. We generated a lethal DENV-2 strain (D220) by 10 additional cycles of subcutaneous inoculation of mice with supernatant from mosquito cells infected with the previously characterized strain D2S10, followed by harvesting of serum. D220 induces mortality at ten-fold lower doses than D2S10 in mice lacking only the alpha/beta interferon (IFN-α/β) receptor in C57BL/6 or 129 backgrounds under both non-enhanced and antibody-enhanced conditions. Sequence analysis of the complete viral genome revealed five amino acid changes between D220 and D2S10, of which two (K122I in envelope and V115A in NS4B) appear to account for the observed phenotypic differences between the viruses. By causing mortality at lower doses in C57BL/6 mice lacking only the IFN-α/β receptor, D220 constitutes an improved tool for study of DENV-induced pathogenesis, as well as for testing potential vaccines and antiviral drugs against DENV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22815273      PMCID: PMC3541791          DOI: 10.1099/vir.0.045088-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  23 in total

Review 1.  Neutralization and antibody-dependent enhancement of dengue viruses.

Authors:  Scott B Halstead
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

2.  Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity.

Authors:  Poornima Parameswaran; Patrick Charlebois; Yolanda Tellez; Andrea Nunez; Elizabeth M Ryan; Christine M Malboeuf; Joshua Z Levin; Niall J Lennon; Angel Balmaseda; Eva Harris; Matthew R Henn
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

Review 3.  Dengue viruses.

Authors:  R W Schlesinger
Journal:  Virol Monogr       Date:  1977

4.  Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease.

Authors:  Raphaël M Zellweger; Tyler R Prestwood; Sujan Shresta
Journal:  Cell Host Microbe       Date:  2010-02-18       Impact factor: 21.023

5.  Genetically modified, live attenuated dengue virus type 3 vaccine candidates.

Authors:  Joseph E Blaney; Christopher T Hanson; Cai-Yen Firestone; Kathryn A Hanley; Brian R Murphy; Stephen S Whitehead
Journal:  Am J Trop Med Hyg       Date:  2004-12       Impact factor: 2.345

6.  A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads.

Authors:  Tyler R Prestwood; Daniil M Prigozhin; Kristin L Sharar; Raphaël M Zellweger; Sujan Shresta
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

7.  Cardif-mediated signaling controls the initial innate response to dengue virus in vivo.

Authors:  Stuart T Perry; Tyler R Prestwood; Steven M Lada; Chris A Benedict; Sujan Shresta
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

8.  New mouse model for dengue virus vaccine testing.

Authors:  A J Johnson; J T Roehrig
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba.

Authors:  Ana B Pérez; Gissel García; Beatriz Sierra; Mayling Alvarez; Susana Vázquez; María V Cabrera; Rosmary Rodríguez; Delfina Rosario; Eric Martínez; Thomas Denny; María G Guzmán
Journal:  J Med Virol       Date:  2004-06       Impact factor: 2.327

Review 10.  Animal models of dengue virus infection.

Authors:  Simona Zompi; Eva Harris
Journal:  Viruses       Date:  2012-01-09       Impact factor: 5.048

View more
  58 in total

1.  A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.

Authors:  Vanessa V Sarathy; Mellodee White; Li Li; Summer R Gorder; Richard B Pyles; Gerald A Campbell; Gregg N Milligan; Nigel Bourne; Alan D T Barrett
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Delineating antibody recognition against Zika virus during natural infection.

Authors:  Lei Yu; Ruoke Wang; Fei Gao; Min Li; Jianying Liu; Jian Wang; Wenxin Hong; Lingzhai Zhao; Yingfen Wen; Chibiao Yin; Hua Wang; Qi Zhang; Yangyang Li; Panpan Zhou; Rudian Zhang; Yang Liu; Xiaoping Tang; Yongjun Guan; Cheng-Feng Qin; Ling Chen; Xuanling Shi; Xia Jin; Gong Cheng; Fuchun Zhang; Linqi Zhang
Journal:  JCI Insight       Date:  2017-06-15

Review 3.  Animal Models of Zika Virus.

Authors:  Michael P Bradley; Claude M Nagamine
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

Review 4.  Mouse models of dengue virus infection for vaccine testing.

Authors:  Vanessa V Sarathy; Gregg N Milligan; Nigel Bourne; Alan D T Barrett
Journal:  Vaccine       Date:  2015-10-23       Impact factor: 3.641

5.  A lethal model of disseminated dengue virus type 1 infection in AG129 mice.

Authors:  Gregg N Milligan; Vanessa V Sarathy; Mellodee M White; M Banks Greenberg; Gerald A Campbell; Richard B Pyles; Alan D T Barrett; Nigel Bourne
Journal:  J Gen Virol       Date:  2017-09-27       Impact factor: 3.891

6.  A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential.

Authors:  Jiaqi Wang; Marco Bardelli; Diego A Espinosa; Mattia Pedotti; Thiam-Seng Ng; Siro Bianchi; Luca Simonelli; Elisa X Y Lim; Mathilde Foglierini; Fabrizia Zatta; Stefano Jaconi; Martina Beltramello; Elisabetta Cameroni; Guntur Fibriansah; Jian Shi; Taylor Barca; Isabel Pagani; Alicia Rubio; Vania Broccoli; Elisa Vicenzi; Victoria Graham; Steven Pullan; Stuart Dowall; Roger Hewson; Simon Jurt; Oliver Zerbe; Karin Stettler; Antonio Lanzavecchia; Federica Sallusto; Andrea Cavalli; Eva Harris; Shee-Mei Lok; Luca Varani; Davide Corti
Journal:  Cell       Date:  2017-09-21       Impact factor: 41.582

7.  Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside.

Authors:  Elizabeth A Bonney
Journal:  Am J Reprod Immunol       Date:  2013-02-28       Impact factor: 3.886

8.  An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses.

Authors:  Aaron F Carlin; Emily M Plummer; Edward A Vizcarra; Nicholas Sheets; Yunichel Joo; William Tang; Jeremy Day; Jay Greenbaum; Christopher K Glass; Michael S Diamond; Sujan Shresta
Journal:  Cell Rep       Date:  2017-11-07       Impact factor: 9.423

9.  Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.

Authors:  Roland Züst; Ying-Xiu Toh; Iris Valdés; Daniela Cerny; Julia Heinrich; Lisset Hermida; Ernesto Marcos; Gerardo Guillén; Ulrich Kalinke; Pei-Yong Shi; Katja Fink
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

10.  The role of the mosquito in a dengue human infection model.

Authors:  Christopher N Mores; Rebecca C Christofferson; Silas A Davidson
Journal:  J Infect Dis       Date:  2014-06-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.